Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know

BACKGROUND: Non‐alcoholic steatohepatitis (NASH) is characterised by hepatic lipid accumulation, cell injury, inflammation and fibrosis. Insulin resistance, a hallmark of type 2 diabetes (T2D) and obesity, is a key pathogenic driver of NASH. Other than difficult‐to‐maintain lifestyle changes, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Barritt, A. Sidney, Marshman, Emma, Noureddin, Mazen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310586/
https://www.ncbi.nlm.nih.gov/pubmed/35266164
http://dx.doi.org/10.1111/apt.16794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310586/
https://www.ncbi.nlm.nih.gov/pubmed/35266164
http://dx.doi.org/10.1111/apt.16794

Ejemplares similares